FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Seturam Katti

Research Profile

Concepts & Ideas

Chemicals & Drugs

Procedures

Anatomy

Cell Line

Physiology

Virus Replication

Phenomena

Static Electricity

Co-author Network

Publications

TOP 3
Raja Solomon Viswas; Kumkum Srivastava; Wahajul Haq; Sunil K Puri; Seturam B Katti
Design, synthesis of 4-aminoquinoline-derived thiazolidines and their antimalarial activity and heme polymerization inhibition studies.
Manish Jain; Seturam B Katti; Manoj Kumar Barthwal; Wahajul Haq; Madhu Dikshit
Synthesis and pharmacological evaluation of novel arginine analogs as potential inhibitors of acetylcholine-induced relaxation in rat thoracic aortic rings.
Vanangamudi Murugesan; Ramesh Paranjape; Reshu Saxena; Rahul Suryawanshi; Vinay S Tiwari; Rajkamal Tripathi; Smita Kulkarni; Nandini Makwana; Seturam B Katti
Lead optimization at C-2 and N-3 positions of thiazolidin-4-ones as HIV-1 non-nucleoside reverse transcriptase inhibitors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Seturam Katti (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Raja Solomon Viswas; Kumkum Srivastava; Wahajul Haq; Sunil K Puri; Seturam B Katti
Design, synthesis of 4-aminoquinoline-derived thiazolidines and their antimalarial activity and heme polymerization inhibition studies.
Journal of enzyme inhibition and medicinal chemistry 2013;28(3):619-26.
2012: Manish Jain; Seturam B Katti; Manoj Kumar Barthwal; Wahajul Haq; Madhu Dikshit
Synthesis and pharmacological evaluation of novel arginine analogs as potential inhibitors of acetylcholine-induced relaxation in rat thoracic aortic rings.
Chemical biology & drug design 2012;79(4):459-69.
2011: Vanangamudi Murugesan; Ramesh Paranjape; Reshu Saxena; Rahul Suryawanshi; Vinay S Tiwari; Rajkamal Tripathi; Smita Kulkarni; Nandini Makwana; Seturam B Katti
Lead optimization at C-2 and N-3 positions of thiazolidin-4-ones as HIV-1 non-nucleoside reverse transcriptase inhibitors.
Bioorganic & medicinal chemistry 2011;19(22):6919-26.
2011: Shreekant Deshpande; Mohammad Goodarzi; Seturam B Katti; Rinki Singh; Yenamandra S Prabhakar
Consensus features of CP-MLR and GA in modeling HIV-1 RT inhibitory activity of 4-benzyl/benzoylpyridin-2-one analogues.
Journal of enzyme inhibition and medicinal chemistry 2011;26(5):696-705.
2011: Ram Raghubir; Saman Raza; Sheeba S Samuel; Rajkumar Verma; Wahajul Haq; Seturam B Katti
Anti-stroke profile of thiazolidin-4-one derivatives in focal cerebral ischemia model in rat.
Chemical biology & drug design 2011;78(3):445-53.
2011: S Deshpande; S Jaiswal; Seturam B Katti; Yenamandra S Prabhakar
CoMFA and CoMSIA analysis of tetrahydroquinolines as potential antimalarial agents.
SAR and QSAR in environmental research 2011;22(5-6):473-88.
2011: Vanangamudi Murugesan; Nidhi Sethi; Yenamandra S Prabhakar; Seturam B Katti
CoMFA and CoMSIA of diverse pyrrolidine analogues as dipeptidyl peptidase IV inhibitors: active site requirements.
Molecular diversity 2011;15(2):457-66.
2010: Raja Solomon Viswas; Wahajul Haq; Martin J Smilkstein; Kumkum Srivastava; SUNIL KUMAR PURI; Seturam B Katti
4-Aminoquinoline derived antimalarials: synthesis, antiplasmodial activity and heme polymerization inhibition studies.
European journal of medicinal chemistry 2010;45(11):4990-6.
2009: Vanangamudi Murugesan; Yenamandra S Prabhakar; Seturam B Katti
CoMFA and CoMSIA studies on thiazolidin-4-one as anti-HIV-1 agents.
Journal of molecular graphics & modelling 2009;27(6):735-43.
2009: Shreekant Deshpande; Raja Solomon Viswas; Seturam B Katti; Yenamandra S Prabhakar
Topological descriptors in modelling antimalarial activity: N(1)-(7-chloro-4-quinolyl)-1,4-bis(3-aminopropyl)piperazine as prototype.
Journal of enzyme inhibition and medicinal chemistry 2009;24(1):94-104.
2008: Ravindra K Rawal; Seturam B Katti; Neerja Kaushik-Basu; Payal Arora; Zhenhua Pan
Non-nucleoside inhibitors of the hepatitis C virus NS5B RNA-dependant RNA polymerase: 2-aryl-3-heteroaryl-1,3-thiazolidin-4-one derivatives.
Bioorganic & medicinal chemistry letters 2008;18(23):6110-4.
2008: Ravindra K Rawal; Renu Tripathi; Seturam B Katti; Christophe Pannecouque; Erik De Clercq
Design and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents.
European journal of medicinal chemistry 2008;43(12):2800-6.
2008: Raja Solomon Viswas; Wahajul Haq; Martin J Smilkstein; Kumkum Srivastava; S Rajakumar; SUNIL KUMAR PURI; Seturam B Katti
Synthesis and antimalarial activity of novel side chain modified antimalarial agents derived from 4-aminoquinoline.
Medicinal chemistry (Shāriqah (United Arab Emirates)) 2008;4(5):446-56.
2008: Ravindra K Rawal; Renu Tripathi; Smitha Kulkarni; R Paranjape; Seturam B Katti; Christophe Pannecouque; Erik De Clercq
2-(2,6-Dihalo-phenyl)-3-heteroaryl-2-ylmethyl-1, 3-thiazolidin-4-ones: anti-HIV agents.
Chemical biology & drug design 2008;72(2):147-54.
2008: Deepa Pandey; Wahajul Haq; Seturam B Katti
New acylides: synthesis of 3-O-[gamma-(4-oxo-2-aryl-thiazolidin-3-yl)butyryl]erythromycin A derivatives.
Beilstein journal of organic chemistry 2008;4():14.
2007: Ravindra K Rawal; Raj Kamal Tripathi; Seturam B Katti; Christophe Pannecouque; Erik De Clercq
Synthesis and biological evaluation of 2,3-diaryl substituted-1,3-thiazolidin-4-ones as anti-HIV agents.
Medicinal chemistry (Shāriqah (United Arab Emirates)) 2007;3(4):355-63.
2007: Ravindra K Rawal; Renu Tripathi; Seturam B Katti; Christophe Pannecouque; Erik De Clercq
Synthesis and evaluation of 2-(2,6-dihalophenyl)-3-pyrimidinyl-1,3-thiazolidin-4-one analogues as anti-HIV-1 agents.
Bioorganic & medicinal chemistry 2007;15(9):3134-42.
2007: Ravindra K Rawal; Renu Tripathi; Seturam B Katti; Christophe Pannecouque; Erik De Clercq
Design, synthesis, and evaluation of 2-aryl-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents.
Bioorganic & medicinal chemistry 2007;15(4):1725-31.
2007: Raja Solomon Viswas; Wahajul Haq; Kumkum Srivastava; SUNIL KUMAR PURI; Seturam B Katti
Synthesis and antimalarial activity of side chain modified 4-aminoquinoline derivatives.
Journal of medicinal chemistry 2007;50(2):394-8.
2007: Ravindra K Rawal; Ashutosh Kumar; Mohammad Imran Siddiqi; Seturam B Katti
Molecular docking studies on 4-thiazolidinones as HIV-1 RT inhibitors.
Journal of molecular modeling 2007;13(1):155-61.
2006: Raja Solomon Viswas; Wahajul Haq; SUNIL KUMAR PURI; Kumkum Srivastava; Seturam B Katti
Design, synthesis and antimalarial activity of a new class of iron chelators.
Medicinal chemistry (Shāriqah (United Arab Emirates)) 2006;2(2):133-8.
2005: Ravindra K Rawal; Yenamandra S Prabhakar; Seturam B Katti; Erik De Clercq
2-(Aryl)-3-furan-2-ylmethyl-thiazolidin-4-ones as selective HIV-RT inhibitors.
Bioorganic & medicinal chemistry 2005;13(24):6771-6.
2005: Ravindra K Rawal; Raja Solomon Viswas; Yenamandra S Prabhakar; Seturam B Katti; Erik De Clercq
Synthesis and QSAR studies on thiazolidinones as anti-HIV agents.
Combinatorial chemistry & high throughput screening 2005;8(5):439-43.
2005: Yenamandra S Prabhakar; Ravindra K Rawal; Manish K Gupta; Raja Solomon Viswas; Seturam B Katti
Topological descriptors in modeling the HIV inhibitory activity of 2-aryl-3-pyridyl-thiazolidin-4-ones.
Combinatorial chemistry & high throughput screening 2005;8(5):431-7.
2005: Raja Solomon Viswas; SUNIL KUMAR PURI; Kumkum Srivastava; Seturam B Katti
Design and synthesis of new antimalarial agents from 4-aminoquinoline.
Bioorganic & medicinal chemistry 2005;13(6):2157-65.
2004: Deepa Pandey; Seturam B Katti; Wahajul Haq; C K M Tripathi
Synthesis and antimicrobial activity of erythromycin-A oxime analogs.
Bioorganic & medicinal chemistry 2004;12(14):3807-13.
2002: Olaf Rosati; Tushar K Srivastava; Seturam B Katti; Jürgen Alves
Importance of phosphate contacts for sequence recognition by EcoRI restriction enzyme.
Biochemical and biophysical research communications 2002;295(1):198-205.
2001: A Kumar; D Dass; M Atreyi; M V Rao; Seturam B Katti
Conformational rigidity introduced by 2',5'-phosphodiester links in DNA.
Nucleosides, nucleotides & nucleic acids 2001;20(10-11):1783-96.
2000: Kunnath P Madhusudanan; Seturam B Katti; Wahajul Haq; P K Misra
Antisense peptide interactions studied by electrospray ionization mass spectrometry.
Journal of mass spectrometry : JMS 2000;35(2):237-41.
2000: S Ghosal; B N KrishnaPrasad; M Khanna; A K Dwivedi; S Singh; A Kumar; Seturam B Katti
3'-deoxyribonucleosides and their derivatives as anti-amoebic agents.
International journal of pharmaceutics 2000;194(1):15-20.
1999: T K Srivastava; Peter Friedhoff; Alfred Pingoud; Seturam B Katti
Application of oligonucleoside methylphosphonates in the studies on phosphodiester hydrolysis by Serratia endonuclease.
Nucleosides & nucleotides 1999;18(9):1945-60.
1999: Kunnath P Madhusudanan; Seturam B Katti; Rajamanickam Vijayalakshmi; Balachandran Unni Nair
Chromium(III) interactions with nucleosides and nucleotides: a mass spectrometric study.
Journal of mass spectrometry : JMS 1999;34(8):880-4.
1996: Thomas Lanio; U Selent; C Wenz; Wolfgang Wende; A Schulz; M Adiraj; Seturam B Katti; Alfred Pingoud
EcoRV-T94V: a mutant restriction endonuclease with an altered substrate specificity towards modified oligodeoxynucleotides.
Protein engineering 1996;9(11):1005-10.
1993: P K Misra; Wahajul Haq; Seturam B Katti; KB Mathur; Ram Raghubir; GK Patnaik; Bhola N Dhawan
Enkephalin antisense peptides: design, synthesis, and biological activity.
Pharmaceutical research 1993;10(5):660-1.